AQUALIS Acquires Stormwater Compliance Solutions, LLC

MORRISVILLE, N.C.- AQUALIS, the nation’s leading provider of sustainable water management, engineering and compliance services for critical infrastructure, announced today it has acquired the assets of Stormwater Compliance Solutions, LLC (SCS). Headquartered in Chester, N.J. with a second office in the Greater Denver area, Stormwater Compliance Solutions has been performing stormwater inspections, maintenance and compliance… Read more »

DFW Named a Top 50 PE Firm for Executives For Third Year

CLEVELAND, OH. – March 12, 2025   PrivateEquityCXO and Falcon Partners have announced 2025’s Top 50 Private Equity Firms who best enable their portfolio company executives to drive maximum returns. Winners are determined through data collected from thousands of sponsor-backed executives highlighting their experiences and rating funds using PE-CXO’s Nine Dimensions of Governance Fit®, a… Read more »

FDA Approves MUDELLA®, from Sebela Women’s Health Inc.

FDA Approves MIUDELLA®, the First Hormone-Free Copper Intrauterine System (IUS) in the U.S. in Over 40 Years, from Sebela Women’s Health Inc. ROSWELL, GA, February 24, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of MIUDELLA® (copper intrauterine system) for… Read more »

Saol Therapeutics announces acceptance of New Drug Application

ROSWELL, Ga, DUBLIN and HAMILTON, Bermuda, Jan. 28, 2025 — Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SL1009, Sodium Dichloroacetate Oral Solution (DCA).  DCA will be used with a proprietary genetic test to treat an orphan pediatric mitochondrial disease, Pyruvate… Read more »